Capstone Development Solutions specializes in developing pharmaceutical products on behalf of the world’s premier healthcare companies. It partners with corporations to lead pharmaceutical development and regulatory services for timely approval of products on their behalf. Water Street established Capstone in 2013 as a new way to support healthcare companies with maximizing their investment in developing pharmaceutical products and medical devices. Dan Robins, PhD, who has more than 20 years of research and development experience, leads the company’s team of scientists and regulatory experts. Al Heller, former CEO of American Pharmaceutical Partners (APPI), serves as chairman. Water Street is one of the few strategic investment firms to offer this unique solution to support companies with advancing their long-term goals for product development.